Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
3.590
+0.250 (7.49%)
At close: Dec 20, 2024, 4:00 PM
3.610
+0.020 (0.56%)
After-hours: Dec 20, 2024, 7:56 PM EST

Q32 Bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Net Income
-60.61-53.74-42.81-37.56
Depreciation & Amortization
0.490.50.370.05
Other Amortization
0.180.090.10.1
Loss (Gain) From Sale of Assets
--0.02-
Stock-Based Compensation
3.661.431.240.75
Other Operating Activities
-16.526.743.18-
Change in Accounts Payable
-1.142.03-1.241.1
Change in Unearned Revenue
-40.34-25.8525.85-
Change in Other Net Operating Assets
45.250.132.342.58
Operating Cash Flow
-67-18.68-10.96-32.98
Capital Expenditures
-0.07-0.01-2.49-0.16
Sale of Property, Plant & Equipment
--0.02-
Investing Cash Flow
19.93-0.01-2.47-0.16
Long-Term Debt Issued
-5.530-
Long-Term Debt Repaid
--5.2--
Net Debt Issued (Repaid)
51.440.330-
Issuance of Common Stock
43.450.110.070.12
Financing Cash Flow
94.90.4130.0720.11
Net Cash Flow
47.82-18.2816.65-13.03
Free Cash Flow
-67.07-18.68-13.44-33.14
Free Cash Flow Margin
---202.10%-
Free Cash Flow Per Share
-5.06-2.58-1.91-5.12
Levered Free Cash Flow
-71.27-40.9-8.73-
Unlevered Free Cash Flow
-70.63-40.67-8.83-
Change in Net Working Capital
26.3412.44-16.57-
Source: S&P Capital IQ. Standard template. Financial Sources.